Related Experiment Video
Updated: Jan 12, 2026

Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
Published on: April 15, 2017
In silico evaluation of cardiac tissue-engineered patch interventions
John Patrick Sayut Jr1, Javiera Jilberto1, Mia Bonini1
1Department of Biomedical Engineering, University of Michigan, 1221 Beal Avenue, Ann Arbor, MI, 48109-2102, USA.
None:
Developing engineered tissue patches from induced pluripotent stem cells that can be incorporated into the heart has been proposed as a potential pathway for improving organ function in patients with severe heart failure. These tissue patches include surface patches, attached to the epicardium of the heart, and thick transmural patches that replace the infarcted region. However, little is known about the impact of cardiac tissue patches on pump function in a patient's heart. In addition, it is not clear what patch structural properties - such as active stress generation, muscle fiber alignment, or material stiffness - may best augment existing heart tissue. Computational modeling can be used to examine the influence of patch properties, illuminating the mechanical impact of cardiac tissue patches in the beating heart. In this work, we computationally implement different cardiac tissue patches to understand the benefits of particular patch types and properties. We find that in transmural cardiac tissue patches, both activation and fiber alignment improve function. A transmural patch generating 10% of healthy active stress can increase stroke volume by 18%, and higher generated active stress in a circumferential muscle fiber orientation can recover stroke volume by over 50%. Furthermore, we find that surface cardiac tissue patches can enhance heart function slightly despite limiting diastolic filling, especially when fibrotic thinning has occurred. These conclusions identify broad design goals for the engineering of cardiac tissue patches to improve heart function.

